
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery
Sponsor : Twist Bioscience
Deal Size : Undisclosed
Deal Type : Partnership
Abveris Announces Antibody Discovery Agreement with Immunitas Using the Berkeley Lights Beacon®
Details : Abveris will utilize its proprietary DiversimAbTM mouse model in combination with its next-generation B cell screening platform, powered by the Berkeley Lights Beacon®, to rapidly discover monoclonal antibodies for use as research reagents and therapeut...
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
October 08, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery
Sponsor : Twist Bioscience
Deal Size : Undisclosed
Deal Type : Partnership

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Ablexis
Deal Size : Undisclosed
Deal Type : Collaboration
Details : The companies together have generated and recovered sequences encoding a rich panel of human antibodies against the S1 spike protein of the SARS-CoV-2 virus.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
April 22, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Ablexis
Deal Size : Undisclosed
Deal Type : Collaboration

Contact Us!